Institute for Translational Medicine
Loyola joined the Institute for Translational Medicine (ITM) in 2018 when Loyola’s participation in the ITM and CTSA was being led by Richard Cooper, MD, MPH, then chair and professor in the department of public health sciences. Since Dr. Cooper’s retirement in June 2020, Elaine Morrato, DrPH, MPH, CPH, Founding Dean of the Parkinson School for Health Sciences and Public Health, has taken over his role.
The days of a sole scientist toiling in his lab are long gone. Rapidly evolving technology makes it easier than ever for researchers to connect with others working in the same area of study, and to access the findings and resources of other institutions.
The National Institutes of Health’s National Center for Advancing Translational Sciences is supporting networks of research institutes with Clinical and Translational Science Awards (CTSA). The CTSA supports networks that collaborate on the translational research process to expedite results from bench to bedside.
In 2018 Loyola University Chicago joined the Institute for Translational Medicine (ITM), the Chicago CTSA hub made up of six local institutions. The ITM has connected more than 1,800 researchers and Chicago-area organizations, funded and trained scientists, and sought to make clinical trials more accessible to local patients.
Other participating medical research centers in Chicago include Rush University Medical Center, NorthShore University Health System, Advocate Health Care, and the Illinois Institute of Technology.
Visit the ITM Research Page and learn about funding opportunities for Loyola University Chicago researchers.
About the Institute for Translational Medicine (ITM)
The Institute for Translational Medicine (ITM) helps you live your best life by making research breakthroughs happen and getting those discoveries into the real world to improve your health as soon as possible.
The ITM is a partnership between the University of Chicago and Rush in collaboration with Advocate Health Care, the Illinois Institute of Technology, Loyola University Chicago, and NorthShore University HealthSystem that’s fueled by about $35 million in grants from the National Center for Advancing Translational Sciences at the National Institutes of Health through its Clinical and Translational Science Awards (CTSA) Program.
We're part of a network of more than 55 CTSA Program-supported hubs across the country working to slash the time it takes to develop and share new treatments and health approaches. We work with you and for you to make participating in health research easy, so that together we improve health care for all.
Join the movement and learn more about how we help researchers, physicians, community members, industry, government organizations, and others. Visit us at chicagoitm.org and connect with us on Facebook, Twitter, Instagram, YouTube, and LinkedIn @ChicagoITM.
This project is supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) through Grant Numbers UL1TR002389, KL2TR002387, and TL1TR00238 that fund the Institute for Translational Medicine (ITM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH